-
A new round of medical insurance negotiations will start!
Time of Update: 2021-11-12
Judging from the experience of the previous rounds of medical insurance negotiations, most innovative drugs have achieved substantial growth in the amount in a short period of time after entering the medical insurance through price-for-volume exchange .
-
Industry: By 2028, the prescription outflow market will exceed 720 billion
Time of Update: 2021-11-12
The industry believes that under the "dual channel" policy, the threshold for future retail companies to undertake outflow prescriptions will be greatly increased, and professional capabilities are required to improve the quality of pharmaceutical services to ensure drug safety .
-
Guangdong established the first smart medical integration innovation platform to lay out the future medical industry ecosystem
Time of Update: 2021-11-12
Cao Rui said that the platform will incorporate high-tech such as big data, artificial intelligence, and sensor technology to promote medical services to become truly informatized and intelligent, and use smart medical care to help "technical burden reduction" and further release more medical resources .
-
The pharmaceutical equipment industry plays a new chapter in development, and innovation becomes the main theme
Time of Update: 2021-11-12
At the same time, it will also accelerate the pace of domestic substitution in the high-end field, and promote the development of the domestic pharmaceutical machinery industry to a new level .
-
Health Commission: The epidemic spreads to 20 provinces and multiple transmission chains are found
Time of Update: 2021-11-12
The spokesperson of the National Health Commission Mi Feng said at a press conference on the State Council's Joint Prevention and Control Mechanism on the 6th that at present, imported local epidemics are reported in many places in China, involving multiple ports, and multiple transmission chains have been discovered .
-
The protein that damages blood vessels in the coronavirus has been identified for the first time
Time of Update: 2021-11-12
Maoz explained: “We found that the incidence of vascular disease and blood coagulation in patients with new coronavirus infection is very high, and many patients have symptoms such as stroke and heart attack .
-
License in model is hot, Shanghai Pharmaceuticals and Hansen Pharmaceutical reached two cooperations within a month
Time of Update: 2021-11-12
On October 9th, Shanghai Pharmaceuticals announced that its subsidiary Shanghai Xinyi and Guizhou Shengnuo have reached a cooperation agreement to obtain the exclusive commissioned production of raw materials and preparations of the new acid inhibitor X842 project in China and the industrial sales rights for all indications .
-
Delisting of well-known pharmaceutical companies!
Time of Update: 2021-11-12
Sales of proprietary Chinese medicines in terminal throats of physical pharmacies in cities in China (unit: ten thousand yuan) Source: Mi Nei. com, China's urban physical pharmacy terminal competition pattern From the perspective of manufacturers, five companies, including Yangzijiang Pharmaceutical, Guilin Sanjin, Golden Throat, Guilong Pharmaceutical, and Jiangzhong Pharmaceutical, have ranked among the top 5 in recent years .
-
The rapid development of medicine drives the demand for pharmaceutical intermediates, which is expected to increase to 231 billion yuan next year
Time of Update: 2021-11-12
After more than 30 years of development, the chemical raw materials and intermediates required for China's pharmaceutical production can basically be matched, and only a small part of it needs to be imported .
-
A new round of medical insurance negotiations will start, and heavyweight CAR-T products are attracting attention
Time of Update: 2021-11-12
According to the industry, in the previous rounds of medical insurance negotiations, many new drugs including PD-1 products have been significantly reduced in price after entering medical insurance.
-
The environmental protection pressure of the pharmaceutical industry continues to increase, and some pharmaceutical companies have been fined one after another
Time of Update: 2021-11-12
For example, this year, the National Development and Reform Commission issued the "Pollution Control, Energy Conservation and Carbon Reduction Central Budget Investment Special Management Measures" (Circular 655), proposing that it will focus on supporting the construction of environmental infrastructure such as sewage and garbage treatment, energy conservation and carbon reduction, resource conservation and high efficiency.
-
The market development momentum is strong, and pharmaceutical companies have gained a lot in the research and development of improved new drugs
Time of Update: 2021-11-12
Data show that in recent years, Chinese pharmaceutical companies have made great gains in the research and development of improved new drugs.
Approved improved new drugs can obtain a certain period of market exclusivity (such as 5 years for new chemical entities, 3 years for new dosage forms), and usually have high technical barriers and patent barriers.
-
The director of Hebei Institute of Disease Control and Virus Analyzes Six Characteristics of Delta Mutant
Time of Update: 2021-11-12
Delta mutant strains spread quickly, replicate quickly in the body, and take a long time to turn negative, which poses greater challenges to the prevention and control of the epidemic .
-
The centralized procurement of Chinese patent medicines continues to advance, and the market will enter the "shuffle" stage
Time of Update: 2021-11-12
On September 26, the Hubei Province Pharmaceutical Price and Bidding Purchasing Management Service Network also issued the "Announcement on Procurement of Proprietary Chinese Patent Medicines by the Inter-provincial Alliance of Centralized Volume Procurement (No.
-
90% gross profit margin can't hold it!
Time of Update: 2021-11-12
This year only two of over 10 Wan TOP10 pharmaceutical stocks that have made profits for each Chinese first sign from 2020 to now Recently, the first-day break of new shares in the A-share market seems to be "normal", but it is still relatively rare to lose more than 10,000 yuan after winning the lottery.
-
With the accelerated pace of innovation, what opportunities and challenges do pharmaceutical companies face?
Time of Update: 2021-11-12
In the field of medicine, with the rapid development of science and technology and the advancement of a series of national and local policies, the pace of innovation in China's pharmaceutical industry is accelerating .
-
Within one day, 2 blockbuster generic drugs have been reviewed
Time of Update: 2021-11-12
On the same day, the NMPA website showed that Huiyu Pharmaceutical's Palonosetron Hydrochloride Hydrochloride Injection was approved to market with the generic 4 types of applications, and it was deemed to have passed the consistency evaluation.
-
Within a week, many senior executives from pharmaceutical companies joined the wave of resignations!
Time of Update: 2021-11-12
Yasheng Pharmaceuticals: Chief Financial Officer Resigns On November 2, Yasheng Pharmaceuticals announced that Mr.
Zhang Su hopes to devote more time and energy to other businesses and has decided to resign as Chief Financial Officer from November 1, 2021 .
-
Health Commission: 74 newly diagnosed cases on the 6th, including 50 from the local area
Time of Update: 2021-11-12
As of 24:00 on November 6, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1169 confirmed cases (including 32 severe cases), a total of 91929 cured and discharged cases, and a total of 4636 deaths.
-
Global new crown cases approaching 250 million delta variants have eased
Time of Update: 2021-11-12
According to a report by the US Chinese website, the number of confirmed cases of the new crown worldwide has approached 250 million on the 7th, and some countries in Eastern Europe are experiencing record outbreaks .
